Mission Bay Capital

Mission Bay Capital

MedCity News

AbbVie & Alector drop Alzheimer’s med from alliance, shifting focus to a 2nd drug

Pulse 2.0

Caribou Biosciences (CRBU) Stock: $28 Price Target From H.C. Wainwright

Pulse 2.0

Calithera Biosciences (CALA) Stock: Why The Price Jumped Today

$20,500,000 Venture capital (Series B)
TechCrunch , MedCity News

GraphWear closes $20.5M Series B for a needle-free, nanotech-powered glucose monitor

MedCity News

CRISPR biotech Caribou Biosciences’ IPO reels in $304M for next-gen cell therapy

$75,000,000 Venture capital (Series B)
AFN

BREAKING: Plant-based cheesemaker Nobell Foods nets $75m from a16z, AgFunder & Breakthrough Energy

VentureBeat

Circle Pharma Appoints Evelyn Wang, PhD as its Vice President, Translational Medicine

$66,000,000 Venture capital (Series C)
VentureBeat

Circle Pharma Raises $66 Million in Series C Financing

$45,000,000 Venture capital (Series B)
FinSMEs , Pulse 2.0

Circle Pharma Raises $45m in Series B Financing

$176,000,000 IPO
PE HUB

VC-backed biotech company Alector goes public

$106,250,000 IPO
PE HUB

VC-backed Principia Biopharma debuts IPO

Xconomy

Entasis Therapeutics and Principia Biopharma Join the IPO Queue

$133,000,000 Venture capital (Series E)
FinSMEs , PE HUB

Biotech Company Alector Raises $133M in Series E Financing

Funding Health Science
$4,200,000 Venture capital (Series A)
Technical.ly

After moving to San Francisco, GraphWear Technologies raises $4.2M Series A

Funding
$35,000,000 Venture capital (Series B)
PE HUB , Venture Funding News

ViewPoint Therapeutics attracts $35 mln Series B

Messaging
$38,600,000 Venture capital (Series C)
Xconomy , vcaonline

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Funding Health Science
$6,500,000 Venture capital (Series A)
PE HUB

Circle Pharma racks up about $6.5 mln

Messaging Data leaks
$1,500,000 Venture capital
site1therapeutics

SiteOne Therapeutics

$1,280,000 Venture capital
Venture Funding News

SiteOne Therapeutics Secures Investment

$8,000,000 Venture capital (Series A)
prnewswire , Venture Funding News

Pionyr Immunotherapeutics Closes Financing with Focus on Developing Antibody-based Immuno-oncology Therapeutics